Iterum Therapeutics Plc Share Price

NASDAQ: ITRM

Small Cap

$0.69

(+0.45%)

as on September 16, 2025 at 1:29 am IST

$₹

Iterum Therapeutics Plc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$0.67
Day's Price Range
$0.7
$0.69
2.90%
Downside
1.45%
Upside
52 Week's Low
52 Week's High
$0.61
52-Week Price Range
$3.02
$0.69
11.48%
Downside
337.68%
Upside

Iterum Therapeutics Plc share price movements today

Previous Close: $0.68
Open: $0.69
Volume: 690.0K
Day's Low - High: $0.67 - $0.7
52 Week Low - High: $0.61 - $3.02

Iterum Therapeutics Plc Historical Returns

1 Month Return: -20.75 %
3 Month Return: -31.6 %
1 Year Return: -35.47 %
3 Year Return: -64.38 %
5 Year Return: -93.06 %

Iterum Therapeutics Plc Stock Fundamentals & Key Indicators

Check Iterum Therapeutics Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$30.5M

EPS (TTM)

-0.33

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-16.8M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Iterum Therapeutics Plc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Iterum Therapeutics Plc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Iterum Therapeutics Plc	BUY	$30.5M	-93.06%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Iterum Therapeutics Plc Stock including INR - Dollar returns

The Iterum Therapeutics Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Iterum Therapeutics Plc investment value today

Current value as on today

₹69,962

Returns

₹30,038

(-30.04%)

Returns from Iterum Therapeutics Plc Stock

₹34,906 (-34.91%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Iterum Therapeutics Plc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Iterum Therapeutics Plc. Average target price of $7

Iterum Therapeutics Plc Share Price Target

Get share price movements and forecasts by analysts on Iterum Therapeutics Plc.

What analysts predicted

90.14%UPSIDE

Target Price

Current Price

$0.69

Analyzed by

8 Analysts

Target

$7.00

Iterum Therapeutics Plc target price $7, a slight upside of 90.14% compared to current price of $0.69. According to 8 analysts rating.

Iterum Therapeutics Plc Stock's Interest Amongst Investors

Search interest for Iterum Therapeutics Plc Stock has increased by 40% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:40% versus previous 30 day period

Iterum Therapeutics Plc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	2	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	-	0	0	0
Operating Income	-8	-10	-16	-11	-6	-3	-4	-3	-3	-5
EBITDA	-8	-11	-2	-11	-6	-4	-5	-5	-3	-5
Interest Expense	0	0	0	0	0	0	0	4	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-9	-12	-3	-12	-7	-4	-5	-6	-4	-6
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-9	-12	-3	-12	-7	-4	-6	-6	-4	-6
Net Profit Margin	0.00%	0.00%	0.00%	-471.83%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Iterum Therapeutics Plc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	0	0	0	-	-	-	-	-
Gross Profit	-	0	0	0	0	-2	-1	-1	0
Operating Income	-13	-29	-76	-102	-32	-24	-30	-47	-18
EBITDA	-13	-29	-76	-101	-36	-83	-39	-34	-18
Interest Expense	-	0	0	0	15	5	2	1	2
Depreciation	-	0	0	0	0	2	1	1	0
Income Before Tax	-13	-28	-76	-102	-51	-90	-44	-37	-24
Income Tax Expense	0	0	0	0	0	0	0	0	0
Net Income	-13	-29	-77	-103	-52	-91	-44	-38	-24
Net Profit Margin	0.00%	-5788.58%	-8867.20%	-278729.73%	0.00%	0.00%	0.00%	0.00%	0.00%

Iterum Therapeutics Plc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-12	-3	-12	-7	-4	-6	-6	-4	-6
Operating Cash Flow	-7	-9	-12	-13	-6	-2	-4	-3	-5
Investing Cash Flow	4	0	13	7	4	5	1	0	0
Financing Cash Flow	0	0	0	7	0	5	13	-8	4
Change in Cash	-3	-8	1	1	-2	8	10	-11	0

Iterum Therapeutics Plc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-29	-77	-103	-52	-91	-44	-38	-24
Operating Cash Flow	-30	-75	-78	-54	-15	-18	-39	-26
Investing Cash Flow	-31	-8	40	0	-54	13	23	18
Financing Cash Flow	45	120	0	64	83	-1	1	26
Change in Cash	-16	36	-39	9	12	-6	-15	18

Global Institutional Holdings in Iterum Therapeutics Plc

Funds	Holdings
New Leaf Venture Partners, L.L.C.	0.81%
Apollon Financial LLC	0.59%
Renaissance Technologies Corp	0.57%
Resources Investment Advisors Inc	0.38%
Two Sigma Investments LLC	0.06%

See all

Insights on Iterum Therapeutics Plc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 106.1%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 180.9%
NEGATIVE IMPACT
Price Dip
In the last 1 month, ITRM stock has moved down by -20.8%

About Iterum Therapeutics Plc

iterum therapeutics plc is an ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. these products are aimed at combatting the global crisis of multi-drug resistant (mdr) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. iterum’s first product is a novel anti-infective compound that has demonstrated potent in-vitro activity vs. a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. for more information on iterum therapeutics please visit www.iterumtx.com.

Organisation	Iterum Therapeutics Plc
Headquarters	3 Dublin Landings, Dublin, Ireland, D01 C4E0
Industry	Health Technology
CEO	Mr. Corey N. Fishman
E-voting on shares	Click here to vote

Key Management of Iterum Therapeutics Plc

Name	Title
Mr. Corey N. Fishman	President, CEO & Director
Ms. Judith M. Matthews	Chief Financial Officer
Dr. Michael W. Dunne M.D.	Strategic Advisor & Director
Mr. Tom Loughman Ph.D.	Senior Vice President of Technical Operations
Dr. Steven I. Aronin M.D.	Senior VP & Head of Clinical Development
Ms. Christine R. Coyne M.B.A.	Chief Commercial Officer

FAQs

What is Iterum Therapeutics Plc share price today?

Iterum Therapeutics Plc share price today is $0.69 as on September 16, 2025 at 1:29 am IST at the close of the market. Iterum Therapeutics Plc share today touched a day high of $0.7 and a low of $0.67.

What is the 52 week high and 52 week low for Iterum Therapeutics Plc share?

Iterum Therapeutics Plc share touched a 52 week high of $3.02 on December 9, 2024 and a 52 week low of $0.61 on September 3, 2025. Iterum Therapeutics Plc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $0.69,which is 77.15% down from its 52 week high and 12.97% up from its 52 week low.

What is Iterum Therapeutics Plc's market capitalisation today?

Iterum Therapeutics Plc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Iterum Therapeutics Plc Stock (ITRM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Iterum Therapeutics Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Iterum Therapeutics Plc Shares that will get you 2.1739 shares as per Iterum Therapeutics Plc share price of $0.69 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Iterum Therapeutics Plc Stock (ITRM) from India?

Indian investors can start investing in Iterum Therapeutics Plc (ITRM) shares with as little as ₹88.042 or $1 (as of September 16, 2025 at 5:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Iterum Therapeutics Plc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 5:43 pm IST). Based on Iterum Therapeutics Plc share’s latest price of $0.69 as on September 16, 2025 at 1:29 am IST, you will get 14.4928 shares of Iterum Therapeutics Plc. Learn more about fractional shares .

What are the returns that Iterum Therapeutics Plc has given to Indian investors in the last 5 years?

Iterum Therapeutics Plc stock has given -93.06% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?